Features of the outpatient management in ischemic heart disease

I n t r o d u c t i o n . Peculiarities of the ischemic heart disease (IHD) course are different in men and women. In general, this problem is not studied enough; however, understanding the specific features of the disease can help to adjust the approach to its diagnosis and early detection, which will improve the prognosis for patients.

A i m . To find peculiarities of the course of IHD and statistically significant differences in the expected manifestations of IHD in female and male outpatients.

M a t e r i a l s a n d m e t h o d s . An analysis of outpatient medical records of 120 men and 110 women with IHD diagnosed between June and December 2024, retrieved from the archive of the University Clinic of Donetsk State Medical University named after M. Gorky, was performed. The following parameters were assessed: age; IHD duration; results of echocardiography (EchoCG) (ejection fraction), electrocardiography (ECG) / Holter monitoring, blood biochemistry; comorbidities (obesity, diabetes mellitus, hypertension), history of myocardial infarction (MI) and interventions.

R e s u l t s . When comparing these groups, significant differences were found in the age and duration of IHD: on aver- age, men were diagnosed with IHD earlier and the IHD history was longer. There were no statistically significant differences in hemodynamic parameters according to EchoCG data, but most patients had signs of left ventricular (LV) remodeling (LV mass index over 120 g/m² had 150 patients). According to ECG/Holter monitoring data, significant differences were found in the number of patients with diagnosed atrioventricular (AV) block: 60 in women and 30 in men, and in all cases men had complete AV block, as a result, they were implanted with pacemakers; while in women, the 1st degree AV blockade prevailed. Statistically significant differences were found in achieving the low-density lipoprotein cholesterol targets (for all patients with IHD ≤1,4 mmol / l): 67% in women vs. 38% in men (p < 0,05). There were more people with a history of MI among men (40 vs. 10 in women). Open coronary revascularization for IHD (multivessel disease / left coronary artery ostium involvement) was performed in 50 men. In the group of women, 20 coronary revascularizations were performed (p = 0,01), and endovascular revascularization was performed significantly more often in this group. Men were diagnosed with NYHA class III, and women – with class II.

C o n c l u s i o n . IHD develops in men on average 5–7 years earlier, and men are much more likely to have a history of MI. With an increase in duration of IHD, the volume of coronary lesions also grows, as well as lesions of other main vessels, in particular, brachiocephalic arteries, progresses, therefore, the open myocardial revascularization is more often used. This trend is observed mainly in men. Men have a higher class of CHF, which may be associated with both a greater number of comorbidities and complications, and a longer duration of IHD.

1. Khandelwal A., Bakir M., Bezaire M. et al. Managing ischemic heart disease in women: role of a Women’s Heart Center. Curr. Atheroscler. Rep. 2021;23(10):56. DOI: 10.1007/s11883-021-00956-x.

2. Mendirichaga R., Jacobs A.K. Sex differences in ischemic heart disease–the paradox persists. JAMA Cardiol. 2020;5(7):754-756. DOI:10.1001/jamacardio.2020.0819.

3. Shinlapawittayatorn K., Chattipakorn S.C., Chattipakorn N. The influence of obese insulin-resistance on the outcome of the ischemia/reperfusion insult to the heart. Curr. Med. Chem. 2018;25(13):1501-1509. DOI: 10.2174/0929867324666170616105639.

4. Solola Nussbaum S., Henry S., Yong C.M. et al. Sex-specific considerations in the presentation, diagnosis, and management of ischemic heart disease: JACC Focus Seminar 2/7.J. Am. Coll. Cardiol. 2022;79(14):1398-1406. DOI: 10.1016/j.jacc.2021.11.065.

5. Rodriguez Lozano P.F., Rrapo Kaso E., Bourque J.M. et al. Cardiovascular imaging for ischemic heart disease in women: time for a paradigm shift. JACC Cardiovasc. Imaging. 2022;15(8):1488-1501. DOI: 10.1016/j.jcmg.2022.01.006.

6. Zherko O.M., Shkrebneva E.I. Ultrasonic diagnosing of the left ventricle remodeling in chronic heart failure with preserved ejection fraction. Vitebsk Medical Journal. 2020;19(2):70-77. DOI: 10.22263/2312-4156.2020.2.70. (In Russ.)

7. Katimova A.A., Kuandyk M.S., Nauanova D.S., Asilbekova G.T. Gender features of coronary heart disease in elderly and senile patients. Vestnik KazNMU. 2021;1:35-39. DOI: 10.53065/kaznmu.2021.73.34.008.(In Russ.)

8. Girerd N., Cleland J., Anker S.D. et al. Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction. Sci. Rep. 2022;12(1):8574. DOI: 10.1038/s41598-022-12385-0.

9. Pastena P., Frye J.T., Ho C. et al. Ischemic cardiomyopathy: epidemiology, pathophysiology, outcomes, and therapeutic options. Heart Fail. Rev. 2024;29(1):287-299. DOI: 10.1007/s10741-023-10377-4.

10. Tsaregorodtsev A.V., Tkachev M.I., Dzyunzya A.N., Seifatova N.B. Does the geometry of the ascending aortic prosthesis affect transvalvular hemodynamics? Experimental study and one clinic’s experience. Complex Issues of Cardiovascular Diseases. 2024;13(2):41-49. DOI: 10.17802/2306-1278-2024-13-2-41-49. (In Russ.)

11. Iaitskaia D.A., Komarov R.N., Tkachev M.I. et al. Historical aspects of mitral valve prosthetics with autopericardium. Complex Issues of Cardiovascular Diseases. 2024;13(2):203-209. DOI: 10.17802/2306-1278-2024-13-2-203-209. (In Russ.)

12. Shao C., Wang J., Tian J., Tang Y.D. Ischemic heart disease: from mechanism to clinical practice. Adv. Exp. Med. Biol. 2020;1177:1-36. DOI: 10.1007/978-981-15-2517-9_1.

13. Suman S., Pravalika J., Manjula P., Farooq U. Gender and CVD – does it really matters? Curr. Probl. Cardiol. 2023;48(5):101604. DOI: 10.1016/j.cpcar-diol.2023.101604.

14. Makowski M., Makowska J.S., Zielińska M. Refractory angina – unsolved problem. Cardiol. Clin. 2020;38(4):629-637. DOI: 10.1016/j.ccl.2020.07.009.

15. Regitz-Zagrosek V., Gebhard C. Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat. Rev. Cardiol. 2023;20(4):236-247. DOI: 10.1038/s41569-022-00797-4.